Northern Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.4M | Buy |
|
|||||
|
2025
Q1 | $80.2M | Buy |
|
|||||
|
2024
Q4 | $115M | Buy |
|
|||||
|
2024
Q3 | $55.5M | Sell |
|
|||||
|
2024
Q2 | $56.6M | Sell |
|
|||||
|
2024
Q1 | $49.9M | Sell |
|
|||||
|
2023
Q4 | $37.5M | Sell |
|
|||||
|
2023
Q3 | $40.6M | Buy |
|
|||||
|
2023
Q2 | $28.5M | Sell |
|
|||||
|
2023
Q1 | $35.6M | Sell |
|
|||||
|
2022
Q4 | $38.5M | Buy |
|
|||||
|
2022
Q3 | $33.8M | Buy |
|
|||||
|
2022
Q2 | $30.9M | Buy |
|
|||||
|
2022
Q1 | $38.5M | Sell |
|
|||||
|
2021
Q4 | $34.3M | Buy |
|
|||||
|
2021
Q3 | $41.5M | Sell |
|
|||||
|
2021
Q2 | $52.9M | Sell |
|
|||||
|
2021
Q1 | $62.6M | Sell |
|
|||||
|
2020
Q4 | $76.1M | Sell |
|
|||||
|
2020
Q3 | $71.7M | Sell |
|
|||||
|
2020
Q2 | $99M | Buy |
|
|||||
|
2020
Q1 | $72M | Buy |
|
|||||
|
2019
Q4 | $75.9M | Buy |
|
|||||
|
2019
Q3 | $52.8M | Buy |
|
|||||
|
2019
Q2 | $70.2M | Buy |
|
|||||
|
2019
Q1 | $106M | Buy |
|
|||||
|
2018
Q4 | $103M | Buy |
|
|||||
|
2018
Q3 | $140M | Buy |
|
|||||
|
2018
Q2 | $153M | Buy |
|
|||||
|
2018
Q1 | $97.7M | Sell |
|
|||||
|
2017
Q4 | $112M | Sell |
|
|||||
|
2017
Q3 | $107M | Sell |
|
|||||
|
2017
Q2 | $207M | Sell |
|
|||||
|
2017
Q1 | $200M | Sell |
|
|||||
|
2016
Q4 | $232M | Buy |
|
|||||
|
2016
Q3 | $56.4M | Buy |
|
|||||
|
2016
Q2 | $58.9M | Sell |
|
|||||
|
2016
Q1 | $68.5M | Sell |
|
|||||
|
2015
Q4 | $82.6M | Sell |
|
|||||
|
2015
Q3 | $76.2M | Buy |
|
|||||
|
2015
Q2 | $77.8M | Buy |
|
|||||
|
2015
Q1 | $80.5M | Buy |
|
|||||
|
2014
Q4 | $66.8M | Sell |
|
|||||
|
2014
Q3 | $67.4M | Sell |
|
|||||
|
2014
Q2 | $66.2M | Sell |
|
|||||
|
2014
Q1 | $67.3M | Buy |
|
|||||
|
2013
Q4 | $36M | Sell |
|
|||||
|
2013
Q3 | $40M | Sell |
|
|||||
|
2013
Q2 | $50.2M | Buy |
|